Bio-Thera Solutions Announces Regulatory Filing Acceptance for BAT2506, a Proposed Biosimilar to Simponi®, in the European Union
Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...
pharmaphorum4d
J&J says ready to fend off Remicade competitor
He noted that in the longer term, J&J 's sales of Simponi Aria (golimumab) continue to grow in rheumatoid arthritis. The company has noted that s J&J has also filed sirukumab in the US and EU ...
Frontiers4d
Toward Overcoming Treatment Failure in Rheumatoid Arthritis
The DMARDs are divided into conventional synthetic (cs) DMARDs (such as methotrexate, leflunomide and sulfasalazine), biological (b) DMARDs [TNF inhibitors (infliximab, etanercept, adalimumab, ...
Yahoo Finance3d
Alvotech (ALVO)
After hours: February 3 at 4:01:47 PM EST Loading Chart for ALVO ...